PharmaDeals: PharmaDeals Review: Table of Contents

<< Previous Issue

Jun 2006 (Vol:2006, Issue: 72)

Next Issue >>

Download pdf of entire issue

Section: Business Commentaries
Let Knowledge Flow Published: 1 Jun-2006
By: Fintan Walton
Abstract Fulltext:
Section: Cartoons
Ready Steady Bio Published: 6 Jun-2006
Details
Section: Deal Trackers
Diquafosol Published: 6 Jun-2006
By: Business Review Editor
Abstract Fulltext:
Section: Distribution & Marketing
Kos to Market SkyePharma’s Flutiform™ Published: 6 Jun-2006
By: Business Review Editor
Abstract Fulltext:
Section: Features
Therapy Focus: Hypoxia-Selective Agents as Anticancer Drugs Published: 1 Jun-2006
By: Business Review Editor
Abstract Fulltext:
Deal Making Spotlights on Big Pharma Published: 1 Jun-2006
By: Business Review Editor
Abstract Fulltext:
Astellas Enters into Yet Another Agreement Published: 1 Jun-2006
By: Business Review Editor
Abstract Fulltext:
Abraxis and AstraZeneca Exchange Agreements Published: 1 Jun-2006
By: Business Review Editor
Abstract Fulltext:
Section: General
IPOs: Still the Exit Strategy of Choice? Published: 6 Jun-2006
By: Business Review Editor
Abstract Fulltext:
ExonHit Therapeutics SA Published: 6 Jun-2006
By: Business Review Editor
Abstract Fulltext:
Section: Licensing
Chelsea Augments its Pipeline Published: 6 Jun-2006
By: Business Review Editor
Abstract Fulltext:
Immunomedics Relights its Therapeutic Potential Published: 6 Jun-2006
By: Business Review Editor
Abstract Fulltext:
Section: Mergers & Acquisitions
AstraZeneca to Acquire Cambridge Antibody Technology Published: 6 Jun-2006
By: Business Review Editor
Abstract Fulltext:
Section: Research & Development
Boehringer Ingelheim’s Bonanza Month Published: 6 Jun-2006
By: Business Review Editor
Abstract Fulltext:

Bookmarks

Bookmark PharmaDeals through one of these social networks.

Table of Contents

Login

Bookmarks